Teligent, Inc. (NASDAQ:TLGT) Short Interest Up 235.4% in December

Share on StockTwits

Teligent, Inc. (NASDAQ:TLGT) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 127,800 shares, a growth of 235.4% from the December 15th total of 38,100 shares. Approximately 2.4% of the company’s shares are short sold. Based on an average daily volume of 5,190,000 shares, the short-interest ratio is currently 0.0 days.

An institutional investor recently bought a new position in Teligent stock. Silverback Asset Management LLC bought a new position in shares of Teligent, Inc. (NASDAQ:TLGT) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 35,998 shares of the company’s stock, valued at approximately $26,000. Silverback Asset Management LLC owned approximately 0.67% of Teligent as of its most recent SEC filing. 31.08% of the stock is owned by institutional investors.

NASDAQ:TLGT opened at $1.07 on Thursday. The stock has a market capitalization of $23.28 million, a P/E ratio of -0.11 and a beta of 1.68. The company has a 50 day moving average price of $0.72 and a 200 day moving average price of $1.20. Teligent has a fifty-two week low of $0.46 and a fifty-two week high of $6.46.

Teligent (NASDAQ:TLGT) last released its earnings results on Wednesday, December 30th. The company reported ($2.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($1.48) by ($0.61).

Teligent Company Profile

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Read More: What are defining characteristics of a correction?

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with's FREE daily email newsletter.